首页> 外文期刊>American journal of critical care >High-dose norepinephrine treatment: Determinants of mortality and futility in critically ill patients
【24h】

High-dose norepinephrine treatment: Determinants of mortality and futility in critically ill patients

机译:大剂量去甲肾上腺素治疗:危重患者死亡率和无效性的决定因素

获取原文
获取原文并翻译 | 示例
           

摘要

Background Critically ill patients with circulatory shock sometimes need rescue treatment with high doses of norepinephrine, a treatment that may be associated with a poor outcome because of excessive vasoconstriction. Objective To evaluate the outcome of treatment and its determinants in patients with circulatory shock who received high doses of norepinephrine in the intensive care unit and to identify indicators of futility for the treatment. Methods A retrospective study was done on 113 consecutive patients with circulatory shock who received 0.9 μg/kg per minute or greater of norepinephrine during at least 1 hour at any time in the intensive care unit. Data were extracted from the electronic patient data management system according to a predefined checklist. Results A total of 39 patients survived for 28 days after admission to the intensive care unit. The variables independently associated with 28-day mortality in multivariable models included low urine flow, high lactate levels, high organ failure score, high prothrombin time, and need for epinephrine cotreatment. The reason, dose, and duration of norepinephrine administration did not have prognostic significance. Scores greater than 40 on the Acute Physiology and Chronic Health Evaluation II, bicarbonate levels less than 9.0 mEq/L, or receipt of an epinephrine dose of 0.25 μg/kg per minute or greater were associated with 100% mortality. Conclusions Although the cause of shock and treatment with norepinephrine were not predictive of death when high doses of the drug were deemed necessary, rescue treatment with high-dose norepinephrine is futile in patients with severe disease and metabolic acidemia.
机译:背景患有循环休克的重症患者有时需要使用大剂量去甲肾上腺素进行抢救治疗,该治疗可能由于过度的血管收缩而导致不良预后。目的评估重症监护病房接受大剂量去甲肾上腺素的循环休克患者的治疗效果及其决定因素,并确定无效的治疗指标。方法对重症监护病房中至少1个小时内连续113例循环休克患者进行回顾性研究,这些患者在至少1小时内每分钟接受0.9μg/ kg或更高的去甲肾上腺素。根据预定义的清单从电子患者数据管理系统中提取数据。结果入院重症监护室后,共有39例患者存活28天。在多变量模型中,与28天死亡率独立相关的变量包括尿量低,乳酸水平高,器官衰竭评分高,凝血酶原时间长和需要肾上腺素协同治疗。去甲肾上腺素给药的原因,剂量和持续时间均无预后意义。急性生理和慢性健康评估II中得分大于40,碳酸氢盐水平低于9.0 mEq / L或肾上腺素剂量为每分钟0.25μg/ kg或更高,则与100%死亡率相关。结论虽然认为必要时大剂量使用该药不会导致休克和使用去甲肾上腺素治疗,但对于重症和代谢性酸血症的患者,大剂量去甲肾上腺素的抢救治疗无效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号